Urinary tract infection in male veterans treatment patterns and outcomes

JAMA Internal Medicine

Volumn 173, Issue 1, 2013, Pages 62-68

  Drekonja, Dimitri M ^a,b   Rector, Thomas S ^a,b   Cutting, Andrea ^a   Johnson, James R ^a,b  

^a Minneapolis Veterans Affairs Health Care System   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; NITROFURANTOIN;

ANTIMICROBIAL THERAPY; CHARLSON COMORBIDITY INDEX; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONFERENCE PAPER; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT DURATION; URINARY TRACT INFECTION; VETERAN;

EID: 84873688080     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/2013.jamainternmed.829     Document Type: Conference Paper

References (29)

1. Saginur R, Nicolle LE; Canadian Infectious Diseases Society Clinical Trials Study Group. Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Arch Intern Med. 1992;152(6):1233-1237.
2. Iravani A, Tice AD, McCarty J, et al; Urinary Tract Infection Study Group. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women: the minimum effective dose [published correction appears in Arch Intern Med. 1995;155(8):871].
3. Arch Intern Med. 1995;155(5):485-494.
4. Tamma PD, Turnbull AE, Milstone AM, Lehmann CU, Sydnor ER, Cosgrove SE. Ventilator-associated tracheitis in children: does antibiotic duration matter? Clin Infect Dis. 2011;52(11):1324-1331.
5. Chastre J, Wolff M, Fagon JY, et al; PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588-2598.
6. Gupta K, Hooton TM, Naber KG, et al; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-e120 http://cid.oxfordjournals.org/content/52/5/e103.long. Accessed September 14, 2012.
7. Lipsky BA. Prostatitis and urinary tract infection in men: what's new; what's true? Am J Med. 1999;106(3):327-334.
8. Nicolle LE. A practical guide to antimicrobial management of complicated urinary tract infection. Drugs Aging. 2001;18(4):243-254.
9. Drekonja DM, Johnson JR. Urinary tract infections. Prim Care. 2008;35(2):345-367, vii.
10. Ulleryd P, Sandberg T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis. 2003;35(1):34-39.
11. Dow G, Rao P, Harding G, et al. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis. 2004;39(5):658-664.
12. Hepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med. 2004;164(15):1669-1674.
13. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48(1):1-12.
14. Griebling TL. Urologic diseases in America project: trends in resource use for urinary tract infections in men. J Urol. 2005;173(4):1288-1294.
15. Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colo-rectal cancer screening among older veterans. Ann Intern Med. 2009;150(7): 465-473.
16. Kashner TM. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care. 1998;36(9):1324-1336.
17. Drekonja DM, Okoye NC, Kuskowski MA, Johnson JR. Appropriateness of urinary tract infection diagnosis and treatment duration. Arch Intern Med. 2010; 170(5):489-490.
18. Smith HS, Hughes JP, Hooton TM, et al. Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis. 1997;25 (1):63-68.
19. Herthelius-Elman M, Möllby R, Nord CE, Winberg J. The effect of amoxycillin on vaginal colonization resistance and normal vaginal flora in monkeys. J Antimicrob Chemother. 1992;29(3):329-340.
20. Herthelius-Elman M, Möllby R, Nord CE, Winberg J. Lack of effect of trimetho-prim and nitrofurantoin on colonization resistance in the vagina of monkeys. Infection. 1992;20(2):105-110.
21. Shaklee J, Zerr DM, Elward A, et al. Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool. Pediatr Infect Dis J. 2011;30(3):e38-e40 http://journals.lww. com/pidj/Abstract/2011/03000/Improving-Surveillance-for-Pediatric-Clostridium. 29.aspx. Accessed September 19, 2012.
22. Schmiedeskamp M, Harpe S, Polk R, Oinonen M, Pakyz A. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009;30(11):1070-1076.
23. Shah K, Pass LA, Cox M, Lanham M, Arnold FW. Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients. J Trauma Acute Care Surg. 2012;72(3):691-695.
24. Drekonja DM, Amundson WH, Decarolis DD, Kuskowski MA, Lederle FA, Johnson JR. Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med. 2011;124(11):1081.e1-1081.e7. http://www.amjmed.com/article/S0002- 9343(11)00495-5/abstract. Accessed September 14, 2012.
25. Nordenstam GR, Brandberg CA, Odén AS, Svanborg Edén CM, Svanborg A. Bacteriuria and mortality in an elderly population. N Engl J Med. 1986;314 (18):1152-1156.
26. van de Sande-Bruinsma N, Grundmann H, Verloo D, et al; European Antimicrobial Resistance Surveillance System Group; European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14(11):1722-1730.
27. Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat. 2000;3(5):303-311.
28. Singh JA. Accuracy of Veterans Affairs databases for diagnoses of chronic diseases. Prev Chronic Dis. 2009;6(4):A126 http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2774640/. Accessed September 14, 2012.
29. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1): 105-116.